The Microbiome in Infant Health and Disease

The Microbiome in Infant Health and Disease

Tuesday, October 19
1:30 PM – 2:30 PM (Central Time)
Location:
CE: 1.0
Level 2 (intermediate knowledge/experience)
Activity Code: 164323

There is increasing evidence that implicates gastrointestinal microbiota as a critical player in the development of diseases in children. Epidemiological studies suggest that early life exposures can alter the gut microbial composition such that differential composition and colonization may influence disease risk. The objective of this session is to review the role of early life exposures in altering the infant gut microbiome and the impact on disease risk, including obesity and allergic diseases.

Planned with the Pediatric Nutrition DPG.

Learning Objectives:

  • Describe what and how early life exposures manipulate the development of the infant microbiome.
  • Characterize the microbial shifts that occur in obesity and allergic diseases.
  • Identify and explain current interventions targeting the gut microbiome in infancy to reduce disease risk.

Performance Indicators:

  • 10.1.2 Conducts the nutrition screening to identify patient risks and level of criticality and to direct services.
  • 6.2.3 Interprets data to make recommendations and to inform decisions.
  • 8.3.7 Integrates new knowledge and skills into practice.

    Moderator(s)

  • The Microbiome in Infant Health and Disease -

    Kimberly Zeender Christy, RD, LD, CLC

    Chair Elect

    PNPG

  • Speaker(s)

  • The Microbiome in Infant Health and Disease -

    Stephanie Harshman, PhD, RD, LD

    Research Fellow, Clinical Dietitian

    Massachusetts General Hospital

  • The Microbiome in Infant Health and Disease -

    Maureen Leonard, MD MMSc

    Assistant Professor, Attending Physician Pediatric Gastroenterologist

    Massachusetts General Hospital